James Topper - Dec 11, 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC. (ALPN)

Role
Director
Signature
/s/ Steve Bailey, Attorney-in-Fact for James N. Topper
Stock symbol
ALPN
Transactions as of
Dec 11, 2023
Transactions value $
$1,850,498
Form type
4
Date filed
12/13/2023, 05:30 PM
Previous filing
May 30, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALPN Common Stock Exercise of in-the-money or at-the-money derivative security $1.85M +145K +9.79% $12.74 1.63M Dec 11, 2023 By: Frazier Life Sciences VIII, L.P. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Warrant (Right to Buy) Exercise of in-the-money or at-the-money derivative security $0 -145K -100% $0.00* 0 Dec 11, 2023 Common Stock 145K $12.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James N. Topper is one of two managing members of FHM LLC. Dr. Topper disclaims beneficial ownership of the securities held by FLS LP except for his pecuniary interest therein, if any.